Iván Ernesto Moreno Plaza: MIGLOBAL Presents: New Wearable Device for Vital Signs

More about wearable technology

Early detection is one of the most important ways people have when there is risk of heart diseases because in those crucial moments, the difference between life and death can depend on a little time detail; with that in mind, science has proposed to use the new revolution of "wearable" technology to provide quick responses to this type situation. The hWear, an Israeli initiative, is a shirt that monitors the heart of the wearer and today MIGLOBAL will give you all the information about this technological advance.

hWear is the result of the hard work of a start-up called HealthWatch, which developed a material called Tech-tile (pun between textiles and technology), which monitors heart activity and vital signs of the user in real time. It is designed in the shape of a shirt that can be worn under any shirt, blouse or dress and is really comfortable to wear. The fabric is filled with sensors that report any irregularities, sending the information via Bluetooth or Wi-Fi to the patient and doctor.

During a cardiac attack, the affected person is often unaware of the situation, as heart problems may appear in different forms; when this happens, the aforementioned events may be left without proper medical checkup, and therefore untreated until the next visit to the doctor, and this time, it could already be too late.

The hWear, an Israeli initiative 

The creators of hWear are insisting that this invention is not a solution to the problem itself, because if the wearer is notified of any anomalous situation, the device only reports the warning, because it is not intended to rectify or cure one of these cases, but to alert, so that that the affected person can take action on the matter and consult a specialist. hWear users can take charge of medical issues before they threaten the patient’s life.

MIGLOBAL Presents New Technology to Stop Smoking

Stop the bad habit

MIGLOBAL is always searching for the latest news about health technology and, for this reason, this company brought today a brand new information about a high-tech device for those who want to stop smoking.

Chrono Therapeutics is an American company that has developed a device designed to help people to stop smoking through a wearable technology, which now goes to the ranks of health. This equipment, which connects directly to the smartphone, has the ability to record the moments of anxiety caused by the cigarette, and helps to control it, releasing doses of nicotine, handled by an algorithm previously stipulated according to its intensity.

Other methods

Patches are tools established and tested in nicotine replacement therapy; however, this method has some limitations. Patches have greater strength at the time of application, but its effectiveness can decrease during the day when its power starts to reduce, which puts smokers at risk of relapse doors. To alleviate this problem, doctors and scientists have sought the answer in science to improve results in the process of giving up this vice.

The SmartStop

Details of the device

The SmartStop is a mobile application, combined with a revolutionary attachment, and is the way the company is taking medical technology to modernize beyond the methods that have been traditionally used, all this in order to put an end to this problem. Chrono Therapeutics has developed a way to provide the timed delivery of drugs transdermally; using this wearable device, the device will offer a better way to liberate smokers from nicotine cravings and, at the end, letting the bad habit behind.

The combination of technologies, which is the main aspect of this company, has joined its team of experienced specialists in medical equipment, information technology experts, pharmacists and designers, who have always managed the concept of wearable technology. This technology has evolved for this initiative to create a device in the style of a wristwatch, to the elegant equipment presenting today, and has achieved great recognition since the early days of its release.

Guy DiPierro, founder of Chrono Therapeutics, first thought of the development of this idea after a personal tragedy that resulted in the death of a relative with lung cancer. The entrepreneur has worked on creating an effective technology and ease of use for the past 10 years, getting support from entities such as the University of Base in Switzerland, and secured funding of up to 2.3 million dollars from The National Cancer Institute.

All the great characteristics